N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide

C31H36N9O5+ — CID 164845868

IUPACN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide
SMILESNC1=N[C@@H](CN2C(=O)CN(c3ccccc3)C2=O)[C@@H]2[NH+]=C(N)N[C@]23N1CC(NC(=O)c1cccc2c1CCC21CCC1)C3(O)O
InChIInChI=1S/C31H35N9O5/c32-26-36-24-21(14-39-23(41)16-38(28(39)43)17-6-2-1-3-7-17)34-27(33)40-15-22(31(44,45)30(24,40)37-26)35-25(42)19-8-4-9-20-18(19)10-13-29(20)11-5-12-29/h1-4,6-9,21-22,24,44-45H,5,10-16H2,(H2,33,34)(H,35,42)(H3,32,36,37)/p+1/t21-,22?,24-,30-/m0/s1
InChIKeyVLKVLLWAVMKRHQ-CFLQOTKGSA-O
MW614.69 g/mol
LogP-2.62
Rot. Bonds5

About N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide

N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide (PubChem CID 164845868) has the molecular formula C31H36N9O5+ and a molecular weight of 614.69 g/mol. Its IUPAC name is N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide.

Molecular Properties

Compound NameN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide
PubChem CID164845868
Molecular FormulaC31H36N9O5+
Molecular Weight614.69 g/mol
Exact Mass614.28
IUPAC NameN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide
SMILESNC1=N[C@@H](CN2C(=O)CN(c3ccccc3)C2=O)[C@@H]2[NH+]=C(N)N[C@]23N1CC(NC(=O)c1cccc2c1CCC21CCC1)C3(O)O
InChIInChI=1S/C31H35N9O5/c32-26-36-24-21(14-39-23(41)16-38(28(39)43)17-6-2-1-3-7-17)34-27(33)40-15-22(31(44,45)30(24,40)37-26)35-25(42)19-8-4-9-20-18(19)10-13-29(20)11-5-12-29/h1-4,6-9,21-22,24,44-45H,5,10-16H2,(H2,33,34)(H,35,42)(H3,32,36,37)/p+1/t21-,22?,24-,30-/m0/s1
InChIKeyVLKVLLWAVMKRHQ-CFLQOTKGSA-O
XLogP-2.62
TPSA203.82 Ų
H-Bond Donors7
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500614.69
LogP ≤ 5-2.62
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide?
The IUPAC name of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide (CID 164845868) is N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide.
What is the SMILES notation for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide?
The canonical SMILES for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide is NC1=N[C@@H](CN2C(=O)CN(c3ccccc3)C2=O)[C@@H]2[NH+]=C(N)N[C@]23N1CC(NC(=O)c1cccc2c1CCC21CCC1)C3(O)O.
What is the InChIKey of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide?
The InChIKey is VLKVLLWAVMKRHQ-CFLQOTKGSA-O. The full InChI is InChI=1S/C31H35N9O5/c32-26-36-24-21(14-39-23(41)16-38(28(39)43)17-6-2-1-3-7-17)34-27(33)40-15-22(31(44,45)30(24,40)37-26)35-25(42)19-8-4-9-20-18(19)10-13-29(20)11-5-12-29/h1-4,6-9,21-22,24,44-45H,5,10-16H2,(H2,33,34)(H,35,42)(H3,32,36,37)/p+1/t21-,22?,24-,30-/m0/s1.
What are the key properties of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide?
N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide has a molecular weight of 614.69 g/mol, XLogP of -2.62, 5 rotatable bonds, 7 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-3-ium-9-yl]spiro[2,3-dihydroindene-1,1'-cyclobutane]-4-carboxamide is sourced from PubChem (CID 164845868), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).